In our August 19 Front Row lecture, Professor Ryan Shenvi invites you to return to chemistry class and learn about remarkable opportunities for creating the medicines of tomorrow. No pop quizzes, no grades. Just a fascinating presentation that will have you on the edge of your seat.
Calibr has now identified and repurposed an FDA-approved drug, clofazimine, used for decades to treat leprosy, as a potential new treatment for cryptosporidiosis.